Log in to save to my catalogue

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_477433

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort

About this item

Full title

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort

Publisher

Netherlands: Elsevier Ltd

Journal title

Cancer epidemiology, 2019-10, Vol.62, p.101584-101584, Article 101584

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

•A cohort of 29,876 healthy volunteers with an average follow-up period of 15 years.•An inverse association between serum IgM levels and bladder cancer risk was found.•Potential role of the humoral immune system in cancer immune surveillance.
The anti-tumour T-cell response in bladder cancer has been shown to correlate with response to treatment...

Alternative Titles

Full title

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_477433

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_477433

Other Identifiers

ISSN

1877-7821

E-ISSN

1877-783X

DOI

10.1016/j.canep.2019.101584

How to access this item